Sorry, Sold Out

Master Hemp #2 CBD 25:1 Feminised Seeds

$12.36$44.86

Please select pack size below

We send seeds in discreet stealth packaging worldwide.

We're Social - Spread the Love

Master Hemp #2 CBD 25:1 Feminised Cannabis Seeds by Medical Marijuana Genetics

Master Hemp #2 CBD 25:1 provides the best qualities of superior hemp strains. It is versatile and strong in a structure allowing it to cope with inclement weather and giving it great vigour during growth. The THC levels are between 0.2 and 0.3 % with CBD averaging 12 %, which fact allows its cultivation in legal territories as ‘hemp’, while trebling the CBD content associated with existing hemp strains such as Finola or Kompolti that average around 4% CBD. It will flourish outdoors and has a berry-like scent.

Master Hemp #2 CBD 25:1 Feminised is 60% indica and is the product of crossing Master Hemp and Kompolti hemp strains. Indoors yields are about 500 gr/m2, taking approx. 60 days of flowering. Outdoors plants produce up to 800 gr. each.

It is used to treat anxiety, autism, PTSD and stress.

Characteristics

    • Genetics: No selection

      Master Hemp X Kompolti

      Variety: No selection

      Mostly Indica

      Flowering Time: No selection

      60 days

      Flowering Type: No selection

      Photoperiod

      Sex: No selection

      Feminised

      THC Content: No selection

      0.2 – 0.3%

      CBD Content: No selection

      High (5% +)

      Yield: No selection

      High

      Grows: No selection

      Greenhouse, Grows Indoors, Grows outdoors

      Medical Conditions: No selection

      , , ,

      Medical Properties: No selection

      Yes

      Effect: No selection

      , ,

      Flavour: No selection

Genetics: No selection

Master Hemp X Kompolti

Variety: No selection

Mostly Indica

Flowering Time: No selection

60 days

Flowering Type: No selection

Photoperiod

Sex: No selection

Feminised

THC Content: No selection

0.2 – 0.3%

CBD Content: No selection

High (5% +)

Yield: No selection

High

Grows: No selection

Greenhouse, Grows Indoors, Grows outdoors

Medical Conditions: No selection

, , ,

Medical Properties: No selection

Yes

Effect: No selection

, ,

Flavour: No selection

Brand

Medical Marijuana Genetics

Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant in 2014. Whilst desperately treating the symptoms of one of the founders mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free. This enabled her to tend to her beloved garden, in the weeks leading up to her death.Medical Marijuana Genetics teamed with award winning breeders from Spain, with the initial aim of creating a line of CBD dominant cannabis strains. Using genetics from a number of well established strains, Medical Marijuana Genetics successfully created Candida (CD-1). Aptly named after the founder’s mother and meaning ‘bright light’ in Latin.Medical Marijuana Genetics have had results ranging from 20.65% CBD with 0.7% THC to 10.65% CBD to 0.39% THC. These percentages represent the highest known consistent ratios in a CBD-rich seed strain ever created in Europe.Medical Marijuana Genetics created a further 12 elite strains using Candida as a parent. They have selected their favourite's of these to release alongside their flagship Candida strain. These have been selected to provide access (within lawful jurisdiction) to the widest range of therapeutics that the cannabis plant, and CBD in particular, has to offer. This includes treatments for symptoms such chronic pain, inflammation, seizures, convulsions, gastro-intestinal disorders, nausea, vomiting, skin conditions, bacterial infections, anxiety, depression, cancer cell growth and much more. All of the strains that are being launched are CBD dominant and have a CBD content of over 8%, but some strains veer towards a 1:1 ratio.In 2017 MMG strains won 5 Spannabis Champions Cups in Barcelona and Madrid. The awards include a 1st (BCN), 2nd and 3rd place (MAD)  in CBD categories for Orinoco OR1, Candida CD1 and Nightingale NN1 and a 2nd and 3rd in the Indica category for as yet unreleased genetics.
Medical marijuana Genetics Cannabis Seed breeders
Leave your review
Rating

Notify me when the item is back in stock.